本頁面由Tiger Trade Technology Pte. Ltd.提供服務

康乃德生物醫藥

2.04
-0.0200-0.97%
盤後2.03-0.0100-0.49%19:58 EDT
成交量:87.80萬
成交額:177.91萬
市值:1.28億
市盈率:-1.71
高:2.10
開:2.07
低:1.94
收:2.06
52周最高:3.82
52周最低:1.23
股本:6,296.39萬
流通股本:2,106.61萬
量比:0.48
換手率:4.17%
股息:- -
股息率:- -
每股收益(TTM):-1.1933
每股收益(LYR):-1.0000
淨資產收益率:-140.51%
總資產收益率:-69.75%
市淨率:4.78
市盈率(LYR):-2.04

資料載入中...

2024/02/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/13

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/24

SEC問詢函

Form CORRESP - Correspondence
2023/04/11

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals